SkinnyRx
US$ 28.19
surmount-1 trial tirzepatide obesity without diabetes weight loss (ZEPBOUND) Approved for Chronic Management in Adults with ✨ The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or SURMOUNT-5: Tirzepatide Bests Semaglutide in
Description
Covered by most private plans
References Eli Lilly
When choosing between them, consider the potential side effects based on your health goals
Ozempic is FDA-approved for type 2 diabetes management, while Wegovy is FDA-approved for chronic weight management in adults with obesity or overweight
